I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Micropulse Laser Therapy for Retinal Conditions
What Is Micropulse Laser Therapy
Micropulse laser therapy is a retinal laser treatment that works differently from traditional approaches. Understanding how it works can help you feel more confident about your care.
Traditional laser photocoagulation applies continuous heat to retinal tissue, creating small burns that seal leaking blood vessels or destroy abnormal areas. While effective for many conditions, this approach leaves permanent scars on the retina. Those scars can affect side vision or central vision, particularly when the treatment area is near the macula (the central part of the retina responsible for sharp, detailed sight).
Micropulse laser therapy uses the same basic technology but delivers energy in extremely short bursts, each lasting only microseconds. The laser fires in a repeating on-and-off cycle. In a standard setting, the laser is active for only about 5 percent of each cycle and off for the remaining 95 percent. This gives the tissue time to cool between pulses, keeping energy levels below the threshold that causes visible damage.
The goal of micropulse therapy is not to burn or scar tissue but to stimulate it. The short pulses of energy activate the retinal pigment epithelium (RPE), a layer of support cells that sits beneath the retina and keeps it nourished and healthy. The energy also activates Muller cells, which are support cells found within the retinal layers themselves.
This stimulation prompts cells to produce heat-shock proteins, which are natural protective molecules that help cells resist stress. Heat-shock proteins work by blocking pathways that lead to inflammation and cell death. Because the energy delivered stays below the damage threshold, no retinal scarring occurs. Research has shown that micropulse delivery requires roughly four to ten times less energy per pulse compared to the level that causes visible tissue damage.
The most widely used wavelength for micropulse laser therapy is 577 nanometers, which produces a yellow beam. This is often referred to as yellow subthreshold micropulse laser (YSML). The 577-nanometer wavelength is well absorbed by the RPE, making it effective while minimizing the energy that reaches surrounding structures.
A retina specialist can adjust several treatment parameters, including wavelength, power level, pulse duration, spot size, and the number of treatment spots. These adjustments allow the treatment to be tailored to each patient's specific condition and anatomy.
Retinal Conditions Treated with Micropulse Laser
Micropulse laser therapy is used to treat several conditions that cause swelling or fluid buildup in and around the macula. Our retina specialists evaluate each patient carefully to determine whether micropulse therapy is the right fit.
Diabetic macular edema (DME) is swelling in the macula caused by leaking blood vessels in people with diabetes. When blood sugar levels are poorly controlled over time, the small blood vessels in the retina can become damaged and start to leak fluid into surrounding tissue. This fluid causes the macula to swell, which blurs or distorts central vision.
Micropulse laser therapy has shown meaningful effectiveness in reducing macular thickness and improving visual acuity in patients with mild to moderate DME. Research suggests it works best when the central part of the macula measures 400 micrometers or less in thickness. For patients with more significant swelling, our specialists may recommend combining micropulse therapy with anti-VEGF injections for better results.
Central serous chorioretinopathy (CSCR) is a condition where fluid collects beneath the retina, often causing blurred or distorted central vision. It most commonly affects younger adults, particularly men, and sometimes resolves on its own. In cases where the fluid persists for several months, treatment may be recommended to help the retina reabsorb it.
Clinical research has compared subthreshold micropulse laser therapy with half-dose photodynamic therapy (PDT, a treatment that uses a light-activated medication to close leaking vessels under the retina) for chronic CSCR. Both approaches produced similar improvements in retinal anatomy and visual function at one year. PDT may resolve the fluid faster in some cases, but micropulse laser therapy remains a valuable option because it avoids the potential side effects associated with the medication used in PDT.
A retinal vein occlusion (RVO) occurs when one of the veins that drains blood from the retina becomes blocked. This blockage causes pressure to build up, leading to swelling and sometimes bleeding in the retina. When the swelling affects the macula, it can significantly reduce central vision.
Micropulse laser therapy has shown meaningful benefit for macular edema caused by branch retinal vein occlusion (BRVO), where a smaller branch vein is affected. Studies have demonstrated reductions in macular thickness and improvements in visual acuity in these patients. In many cases, micropulse therapy is used alongside anti-VEGF injections to help reduce the total number of injections needed over time.
Who May Benefit from Micropulse Laser
Not every patient with a retinal condition is an ideal candidate for micropulse laser therapy. Our retina specialists take a careful, individualized approach to determine whether this treatment is right for each person.
Micropulse laser therapy tends to work best for patients with mild to moderate macular edema. Research consistently shows that patients with a central retinal thickness of 400 micrometers or less respond most favorably. Many patients are considered for micropulse therapy after completing an initial series of anti-VEGF injections and showing a partial but incomplete response.
A retina specialist will evaluate the type of condition, the severity of swelling, and the patient's prior treatment history before recommending micropulse laser therapy. The goal is always to match the right treatment to each individual situation.
The degree of macular swelling plays an important role in how well micropulse laser therapy works. Patients with thinner retinas, generally at or below 400 micrometers in central thickness, tend to see better results with micropulse therapy alone. Patients with more significant swelling can still benefit from micropulse treatment, but typically do best with a combination approach that includes ongoing anti-VEGF injections rather than micropulse as a standalone option.
The conditions that micropulse laser treats each have their own risk factors. For diabetic macular edema, poorly controlled blood sugar, high blood pressure, elevated cholesterol, and longer duration of diabetes all increase risk. For central serous chorioretinopathy, stress, use of corticosteroid medications, and certain personality traits have been associated with higher risk. Retinal vein occlusion is linked to high blood pressure, diabetes, glaucoma (increased pressure inside the eye that can damage the optic nerve), and blood clotting disorders.
Managing these underlying health conditions is an important part of protecting your retinal health and can also influence how well any treatment works. Our specialists are glad to collaborate with your other healthcare providers when needed.
What to Expect During Your Appointment
Micropulse laser therapy is performed in our office as an outpatient procedure. Most patients are pleasantly surprised by how quick and comfortable the experience is. Here is what you can expect at each stage.
Before your micropulse laser session, your retina specialist will perform a thorough eye examination. This typically includes optical coherence tomography (OCT), a painless imaging test that creates detailed cross-sectional pictures of the retina to measure thickness and detect swelling. Fluorescein angiography (a test that uses a safe dye to photograph the blood vessels inside the eye) may also be performed to pinpoint areas of leakage.
These images guide the specialist in planning the treatment area and selecting the correct laser settings for your condition. Pupil-dilating eye drops will be applied before the procedure begins and may cause temporary blurring of your near vision for a few hours.
The treatment itself takes place in our office and typically lasts between 10 and 20 minutes. Numbing eye drops are placed in the eye, and a special contact lens is positioned on the surface of the eye to focus the laser precisely onto the retina. Most patients report little to no discomfort. You may notice brief flashes of light as the laser is applied, but this is normal and not painful.
Our specialists follow established guidelines for laser settings, including the use of a 577-nanometer wavelength, a carefully calibrated duty cycle (the percentage of time the laser is actually firing), and spot sizes and power levels that keep energy well below the tissue damage threshold. These settings are individualized for each patient and condition.
There is generally no downtime after micropulse laser therapy. Your vision may be mildly blurry for a few hours due to the dilating drops and the contact lens used during the procedure, but most patients return to normal activities the same day. Because the drops temporarily affect your focus and may widen your pupils, we recommend arranging a ride home rather than driving immediately after the appointment.
Follow-up appointments are an essential part of your care. Your retina specialist will use OCT imaging to monitor how your retina responds over time. Because micropulse laser does not leave visible scars, progress is tracked by measuring changes in retinal thickness and visual acuity at each visit. Some patients benefit from additional treatment sessions based on these results.
Treatment Outcomes and Effectiveness
A growing body of research supports the effectiveness and safety of micropulse laser therapy for appropriate candidates. Here is what the evidence shows.
Studies have consistently shown that micropulse laser therapy can reduce macular thickness, help the retina reabsorb excess fluid, and improve visual acuity in patients with diabetic macular edema and macular edema from retinal vein occlusion. A key advantage is the absence of retinal scarring, which means the treatment can be safely repeated if swelling returns or does not fully resolve after the first session.
For patients with mild to moderate macular edema and a central retinal thickness below 400 micrometers, micropulse therapy alone has proven to be both safe and effective in carefully selected cases. Professional retinal laser guidelines have recognized it as a viable first-line or complementary treatment in the right situations.
One of the most encouraging findings in recent research is that combining micropulse laser therapy with anti-VEGF injections (medications injected into the eye to reduce abnormal blood vessel growth and leakage) can meaningfully lower the total number of injections a patient needs. A published analysis found that patients receiving both treatments required an average of roughly two fewer injections per year compared to those receiving injections alone, a difference that was statistically significant.
Anti-VEGF medications commonly used alongside micropulse therapy include aflibercept, ranibizumab, bevacizumab (used off-label for retinal conditions), and faricimab, among others. The choice of medication and dosing schedule is always determined by your retina specialist based on your individual condition and how you respond to treatment over time.
For many patients, one of the most meaningful benefits of adding micropulse laser therapy to their treatment plan is reducing the frequency of office visits and injections. Fewer injections can mean lower overall treatment burden, less time away from daily life, and a reduced risk of injection-related side effects over the long term. Your retina specialist can help you understand whether a combination approach is appropriate for your situation.
Micropulse laser therapy has a strong safety record. Because the laser energy stays below the visible damage threshold, properly performed treatments do not produce lasting scars, burns, or structural changes to the retina. Very few complications have been reported in the medical literature for this approach.
The primary concern with this treatment is not overtreatment but rather undertreatment. Because no visible marks confirm that the laser reached its intended target, some patients may not respond as fully as expected. In these situations, the treatment settings can be adjusted, or additional sessions can be scheduled. Ongoing research continues to refine optimal settings so that more patients benefit from each treatment session.
Living Well with a Retinal Condition
Micropulse laser therapy is one part of a broader strategy for managing retinal health over time. Understanding what to expect helps patients stay engaged and informed in their own care.
Micropulse laser therapy is not a one-time cure for retinal conditions. Most patients require ongoing monitoring and may need repeat treatments or continued anti-VEGF injections over time. The primary goals of treatment are to reduce swelling, preserve existing vision, and slow the progression of the underlying disease.
Visual improvement after micropulse therapy may be gradual rather than immediate. Some patients experience meaningful gains in visual acuity, while others see their vision stabilize rather than improve. Both outcomes represent real success in preventing further vision loss, which is often the most important measure of treatment effectiveness.
For patients with diabetic macular edema, controlling blood sugar, blood pressure, and cholesterol levels is essential. These factors directly affect the health of the retinal blood vessels and influence how well any treatment works. Partnering closely with your primary care physician or endocrinologist to manage these conditions can meaningfully improve your retinal outcomes.
For patients with central serous chorioretinopathy, reducing stress and avoiding corticosteroid medications when possible may help lower the risk of recurrence. If corticosteroids are medically necessary for another condition, our specialists can work with your other physicians to explore alternatives or adjust your retinal treatment plan as needed.
Consistent follow-up with your retina specialist is critical when undergoing micropulse laser therapy. OCT imaging at follow-up visits allows the specialist to track changes in retinal thickness, monitor visual acuity, and determine whether additional treatment is needed. Skipping appointments can allow swelling to worsen without noticeable changes in your vision, making it harder to respond effectively before further damage occurs.
When to See a Retina Specialist
Knowing when to seek care is an important part of protecting your vision. Some situations call for routine monitoring, while others require immediate attention.
Anyone living with diabetes, a history of retinal vein occlusion, or a diagnosis of central serous chorioretinopathy should have regular dilated eye examinations. An optometrist or general ophthalmologist can screen for early retinal changes and refer patients to a retina specialist when additional evaluation or treatment is needed. Patients already diagnosed with macular edema should discuss all available treatment options, including micropulse laser therapy, with their retina specialist.
Certain vision symptoms require urgent evaluation and should never be ignored or delayed. If you experience any of the following, contact a retina specialist right away or go to your nearest emergency room:
- A sudden increase in floaters (spots, threads, or shapes drifting through your vision)
- Flashes of light, especially at the edges of your vision
- A curtain, shadow, or dark area spreading across your visual field
- Sudden loss of vision in one eye
These symptoms may signal a retinal tear or retinal detachment (when the retina separates from the back wall of the eye), which is a true ocular emergency. Prompt treatment can make a significant difference in preserving vision.
Frequently Asked Questions
Here are answers to questions our patients commonly ask about micropulse laser therapy. If you have additional questions, our team is happy to help at any of our four offices.
Most patients find the procedure very comfortable. Numbing drops are placed in the eye before treatment begins, so you should not feel pain during the laser application. Some patients notice a mild sense of warmth or see brief flashes of light as the laser fires, but these sensations are not painful. The procedure does not require sedation or general anesthesia, and there is no physical recovery period afterward. You can plan to return to your normal routine the same day.
The number of sessions depends on your specific condition and how your retina responds. Some patients see meaningful improvement after a single session, while others benefit from two or more treatments over several months. Because micropulse laser does not scar the retina, repeating the treatment is safe when indicated. Rather than following a fixed schedule, your retina specialist will use your OCT imaging at each follow-up visit to guide that decision based on how your retina is actually responding.
For some patients with mild to moderate macular edema, micropulse laser therapy may be effective as a standalone approach, potentially reducing or eliminating the need for injections during that period. For others, especially those with more significant swelling or conditions that require sustained suppression of abnormal blood vessel activity, the most effective strategy combines both treatments. Adding micropulse therapy to an injection regimen can reduce how often injections are needed, but whether it can fully replace them depends on factors your retina specialist will assess based on your imaging and clinical response over time.
Micropulse laser therapy has an excellent safety profile when performed with proper technique and settings. Because the energy stays below the tissue damage threshold, the risk of scarring or structural injury to the retina is very low. The most common concern is not overtreatment but rather that the laser may not stimulate the target tissue as effectively as intended in some cases. This is not painful or visible to you, but it may prompt your retina specialist to recommend adjusted settings or an additional session if your response at follow-up is not as expected.
Improvement after micropulse laser therapy is often gradual rather than immediate. Your retina specialist will typically schedule a follow-up OCT scan within several weeks after your first session to assess changes in retinal thickness. Noticeable visual improvement, when it occurs, may take several weeks to months to become apparent. In some cases, the primary goal is stabilization rather than improvement, and your specialist will help you interpret your results in the context of your overall treatment plan so that realistic expectations are in place from the start.
Prior traditional laser treatment does not automatically rule out micropulse laser therapy, but your retina specialist will carefully review your history and current retinal imaging before making any recommendations. In areas that have already been scarred by conventional laser, the tissue structure is different, and both the treatment goals and the appropriate parameters may need to be adjusted. A thorough pre-treatment evaluation helps ensure that any approach chosen is both safe and well-suited to your current retinal condition.
Schedule a Consultation with Our Team
New England Retina Associates is a retina-only practice serving patients across Connecticut, with four offices staffed by fellowship-trained vitreoretinal surgeons who specialize in the full range of medical and surgical retinal care, including micropulse laser therapy. Whether you were referred by your eye doctor or are seeking a second opinion, we welcome you to schedule a consultation at a location convenient for you. Our team is committed to helping you understand your options and to working alongside you toward the best possible outcome for your vision.
30 Years of Care & Commitment
